The following new psychoactive substances shall be subjected to control measures across the Union:
4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe);
3,4-dichloro-N-[[1-dimethylamino)cyclohexyl]methyl]benzamide (AH-7921);
3,4-methylenedioxypyrovalerone (MDPV);
2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine).